HOME
ABOUT
OUR TEAM
mRNA TECHNOLOGY
PIPELINE
MER-101
NEWS
CONTACT
PRESS RELEASE
BIOTECH UPDATES
PRESS RELEASE DATE
All Dates
2026
(2)
2025
(1)
2023
(1)
2022
(3)
October 6, 2026
Merlin Biotech Receives Another Phase I SBIR To Investigate MER-101 in Head and Neck Cancer
January 6, 2026
Merlin Biotech Receives NIH Contract To Test MER-101 In Combination with Checkpoint Inhibitors
February 11, 2025
Merlin Biotech Receives Investment From The Alliance for Health Equity
January 20, 2023
Merlin Biotech Reveals Novel Cancer Immunotherapy at Biotech Showcase 2023
November 8, 2022
MERLIN Biotech CEO to present at BioFuture Nov. 8
October 13, 2022
MERLIN Biotech wins pitch competition at Biotech Week Boston
1
2
next